Benefits of Testing for the G12D Mutation of the KRAS Gene in Hepatocellular Carcinoma (HCC) in Senegal
Background: The mutation of the KRAS proto-oncogene is frequently detected in various cancers, including hepatocellular carcinoma (HCC). This mutation often results in the failure of treatments based on tyrosine kinase receptor inhibitors. The study's objective was to investigate mutations of codon 12 and 13 of the...